| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.18B | $2.93B | $3.01B |
| YoY Revenue Growth % | +8.7% | -2.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $471.1M | $416.8M | $433.7M |
| Operating Margin % | 14.8% | 14.2% | 14.4% |
| Net Income (GAAP) | $286.6M | -$176.1M | -$11.8M |
| EBITDA (Normalized) | $1.04B | $871.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $693.3M | $581.4M | $637.9M |
| Capital Expenditures (CapEx) | $715.9M | $567.9M | — |
| Free Cash Flow (FCF) | -$22.7M | $13.5M | $637.9M |
| FCF Margin % | -0.7% | 0.5% | 21.2% |
| Return on Invested Capital (ROIC %) | 21.1% | 14.6% | — |
| Cash & Short-Term Equivalents | $940.7M | $389.7M | — |
| Total Debt (Short + Long Term) | $2.12B | $2.51B | — |
| Total Stockholders' Equity | $590.7M | $135.0M | — |